Analyst stock forecast
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares Stock Forecast and Analyst Price Target
KNSA analyst target range, upside, consensus rating and coverage count.
Direct answer
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares's average price target is $98.00.
The target implies +26.5% from the recorded current price, and the consensus rating is Strong Buy.
The verified range is $87.00 to $108.00, with 8 analysts in the current consensus when available.
Forecast evidence checked August 12, 2026.
Get free Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $77.50
- Average price target
- $98.00
- High price target
- $108.00
- Low price target
- $87.00
- Target upside
- +26.5%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026
Explore related company data
View Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares's price target rangeView Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares's target upside or downsideView Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares's analyst consensus ratingReturn to Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares profile